<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Myelosuppressive cytokines, in particular IFN-gamma and TNF-alpha, play an important role in the pathogenesis of idiopathic <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in humans </plain></SENT>
<SENT sid="1" pm="."><plain>It is unknown whether these negative regulators of hemopoiesis suppress stem cells by activating a common signaling cascade or via distinct nonoverlapping pathways </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we provide evidence that a common element in signaling for IFN-gamma and TNF-alpha in human hemopoietic progenitors is the p38/MapKapK-2 signaling cascade </plain></SENT>
<SENT sid="3" pm="."><plain>Our studies indicate that pharmacological inhibition of p38 reverses the suppressive effects of IFN-gamma and TNF-alpha on <z:mpath ids='MPATH_458'>normal</z:mpath> human bone marrow-derived erythroid and myeloid progenitors </plain></SENT>
<SENT sid="4" pm="."><plain>Most importantly, inhibition of p38 strongly enhances hemopoietic progenitor colony formation from <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> bone marrows in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, p38 appears to play a critical role in the pathogenesis of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, suggesting that selective pharmacological inhibitors of this kinase may prove useful in the treatment of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and other cytokine-mediated <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndromes </plain></SENT>
</text></document>